koherus

Koherus BioSciences, Inc. is a biopharmaceutical company focused on the development, commercialization, and manufacturing of biopharmaceutical products. The company's mission is to improve patient lives by providing access to innovative and affordable biologic therapies. Koherus operates primarily in the United States and is headquartered in Redwood City, California.

The company's product portfolio includes biosimilars and proprietary biologics. Biosimilars are approved versions of existing biologic medicines that are highly similar to a reference product in terms of safety, purity, and potency. By offering biosimilars, Koherus aims to increase competition and reduce the cost of biologic treatments, thereby improving patient access.

Koherus has established a strategic approach to product development and commercialization, often involving partnerships and licensing agreements. Their focus is on identifying and bringing to market biologics in therapeutic areas with significant unmet needs or where cost-effective alternatives are desired. The company emphasizes its manufacturing capabilities and quality control processes to ensure the reliability and efficacy of its products.

The financial performance and market presence of Koherus are subject to the dynamics of the pharmaceutical industry, including regulatory approvals, market competition, and healthcare reimbursement policies. The company's growth strategy involves expanding its product pipeline and its commercial reach within the United States healthcare system.